Pharmacokinetic Considerations in the Eradication of Helicobacter Pylori
- 1 March 2000
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 38 (3), 243-270
- https://doi.org/10.2165/00003088-200038030-00004
Abstract
No abstract availableKeywords
This publication has 161 references indexed in Scilit:
- Pharmacokinetics and Pharmacodynamics of H2-Receptor Antagonists in Patients with Renal InsufficiencyClinical Pharmacokinetics, 1993
- Pharmacokinetic Study of Omeprazole in Elderly Healthy VolunteersClinical Pharmacokinetics, 1992
- Clinical Pharmacokinetics of Metronidazole and Other Nitroimidazole Anti-InfectivesClinical Pharmacokinetics, 1992
- AzithromycinDrugs, 1992
- OmeprazoleDrugs, 1991
- Colloidal Bismuth SubcitrateDrugs, 1988
- Pharmacokinetics of Tinidazole in Male and Female SubjectsThe Journal of Clinical Pharmacology, 1982
- Absorption of salicylate and bismuth from a bismuthsubsalicylate-containing compound (Pepto-Bismol)The Journal of Pediatrics, 1981
- Interactions with the Absorption of TetracyclinesDrugs, 1976
- Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with referencesJournal of Pharmacokinetics and Biopharmaceutics, 1975